WW
ASLN

Waterfront Wealth’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Waterfront Wealth’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,840
Closed -$6.82K – 265
2024
Q2 		$6.82K Buy
2,840
+250
+10% +$886 ﹤0.01% 245
2024
Q1 		$9.12K Sell
2,590
-2,528
-49% -$12.7K ﹤0.01% 243
2023
Q4 		$21.4K Sell
5,118
-1,062
-17% -$8.01K 0.01% 248
2023
Q3 		$57.8K Sell
6,180
-1,434
-19% -$26.3K 0.02% 244
2023
Q2 		$152K Buy
7,614
+445
+6% +$13.8K 0.05% 246
2023
Q1 		$165K Buy
7,169
+125
+2% +$3.38K 0.05% 238
2022
Q4 		$210K Sell
7,044
-1,969
-22% -$38K 0.07% 233
2022
Q3 		$156K Buy
9,013
+188
+2% +$4.85K 0.06% 234
2022
Q2 		$175K Buy
8,825
+600
+7% +$13.3K 0.07% 228
2022
Q1 		$270K Buy
8,225
+1,475
+22% +$54.8K 0.1% 202
2021
Q4 		$302K Buy
+6,750
New +$405K 0.12% 168

Other funds holding ASLN

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Waterfront Wealth's ASLN Position: Q3 2024 in Review

Waterfront Wealth sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 2,840 shares — an estimated $6.82K sold.

Waterfront Wealth first reported a position in ASLN in Q4 2021 and held it in 11 quarters. The position peaked at $302K in Q4 2021. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

  • Waterfront Wealth reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Waterfront Wealth sold 2,840 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $6.82K.
  • Waterfront Wealth first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2021 and held it in 11 quarters.
  • Waterfront Wealth's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $302K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Waterfront Wealth's 13F filing for Q3 2024, filed 31 Oct 2024.